Skip to main content
Premium Trial:

Request an Annual Quote

Todd Golub, Jutta Heim, Olli Kallioniemi, Achim Feurer, Curt LaBelle, Paul Herring, Anthony Martin, Wendell Wierenga, Mary Callan


Todd Golub has been named to the scientific advisory board of Ardais of Lexington, Mass. Golub is director for cancer genomics at the Whitehead/MIT Center for Genome Research, and pediatric oncologist at Dana-Farber Cancer Institute. Golub has an MD from the University of Chicago Pritzker School of Medicine and is an investigator with the Howard Hughes Medical Institute.

Jutta Heim and Olli Kallioniemi have joined the scientific advisory board of


, a Dutch microarray technology startup. Heim heads the lead discovery center of

Novartis. Kallioniemi

is professor of medical biotechnology at the VTT Technical Research Center of Finland. Previously, he was head of the translational genomics branch at the National Human Genome Research Institute at NIH.

Achim Feurer, 40, has been named director of medicinal chemistry for Heidelberg, Germany-based Graffinity Pharmaceuticals. Feurer was project manager for the medicinal chemistry department of the pharmaceutical unit of Bayer in Wuppertal, Germany. Graffinity combines microarrays and label-free detection systems to assay compound-protein interactions.

Curt LaBelle joins the health care venture capital firm Tullis-Dickerson & Co. of Greenwich, Conn., as senior associate. LaBelle was previously at Convergent Ventures of Los Angeles. LaBelle has an MD/MBA from Columbia University and a BS in economics from Brigham Young University.

Agilent Technologies created a new scientific advisory board and appointed: Paul Herring, director of corporate research at Novartis International; Anthony Martin, president and CEO of Molecular Probes; Mark Skolnick, founder of Myriad Genetics; and Wendell Wierenga, CEO of Syrrx.

Mary Callan, former director of business development at Exelixis, has been appointed vice president of business development at Morphotek of Philadelphia.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.